Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Long-Term Deferred Tax (2018 - 2025)

Skinvisible's Long-Term Deferred Tax history spans 8 years, with the latest figure at $8.6 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 2.38% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 million, a 2.38% increase, with the full-year FY2025 number at $8.6 million, up 2.38% from a year prior.
  • Long-Term Deferred Tax hit $8.6 million in Q4 2025 for Skinvisible, up from $8.4 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for SKVI hit a ceiling of $8.6 million in Q4 2025 and a floor of $3.3 million in Q4 2021.
  • Historically, Long-Term Deferred Tax has averaged $7.3 million across 5 years, with a median of $8.3 million in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: soared 136.36% in 2022 and later increased 1.2% in 2024.
  • Tracing SKVI's Long-Term Deferred Tax over 5 years: stood at $3.3 million in 2021, then skyrocketed by 136.36% to $7.8 million in 2022, then rose by 6.41% to $8.3 million in 2023, then grew by 1.2% to $8.4 million in 2024, then grew by 2.38% to $8.6 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for SKVI at $8.6 million in Q4 2025, $8.4 million in Q4 2024, and $8.3 million in Q4 2023.